> GlaxoSmithKline joins a lineup of big vaccine makers reporting that a single shot of its new swine flu vaccine is demonstrating a strong immune response in clinical trials. A single-dose approach to the pandemic has the potential to significantly boost the number of people vaccinated against the new flu. Report
> Xoma's shares jumped after the biotech company said it would pay off a loan to Goldman Sachs Specialty Holdings by handing the royalty rights to Lucentis to Genentech. Xoma gets a $25 million payment. Report
> Almac Diagnostics has inked a deal with Lilly UK to develop a companion diagnostic test for a combo lung cancer drug. Story
> An independent monitoring committee is recommending the continuation of GTx's late-stage trial of its prostate cancer therapy toremifene. Release
> The FDA has approved GenSpera's clinical trials of its cancer drug G-202. Report
Pharma News
> The Senate healthcare plan championed by Sen. Max Baucus is about to get a boost from pharma. The industry trade group PhRMA is prepping a series of TV ads that specifically support Baucus's version of healthcare reform, the New York Times reports. Report
> What if you threw a personalized medicine party and lots of people got lost along the way? Apparently, that's what's happening with Roche's breast cancer drug Herceptin. Report
> It's back to the drawing board for Johnson & Johnson and Elan. In the wake of a judge's ruling in favor of Elan's Tysabri partner Biogen Idec, J&J is lobbying for a lower price for their $1.5 billion deal, Reuters reports. Report
> U.S. District Judge John Keenan followed through on his wordFriday and declared a mistrial in the bellwether case against Merck over the drugmaker's osteoporosis drug Fosamax. Report
Biotech IT News
> Virtify has unveiled a software-as-a-service solution for managing clinical trial disclosure requirements. The Virtx CTRR Clinical Trial Registry & Results solution automates compliance with global regulatory mandates, according to an announcement. Article
> The European Bioinformatics Institute recently got a big data storage boost--$16.6 million worth--from the British Biotechnology and Biological Sciences Research Council. Article
> An attempt to simplify complex discovery software has gone beyond simplification to researcher social networking. Article
And Finally... Scientists say the tiger is brainier than the lion. Release